A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia


Tugal O., Yazici K.

16th Congress of the European-College-of-Neuropsychopharmacology, PRAGUE, Czech Republic, 20 - 24 September 2003, vol.13 identifier